Lawrence, R. E. (2022). Antipsychotic Maintenance Treatment for Patients With Schizophrenia: The Need for Placebo-Controlled Trials and The Risk of Paradigm Shifts. Schizophrenia Bulletin Open, 3(1). https://doi.org/10.1093/schizbullopen/sgac058

Marazia, C., Rucci, P., Fangerau, H., Voßberg, D., Rolfes, V., Iozzino, L., Iommi, M., Gosek, P., Heitzman, J., Ferrari, C., Macis, A., Markiewicz, I., Picchioni, M., Salize, H. J., Stompe, T., Wancata, J., Appelbaum, P. S., & de Girolamo, G. (2022). Treatment Decision-Making Capacity in Forensic vs Non-forensic Psychiatric Patients: A European Comparison. Schizophrenia Bulletin Open, 3(1). https://doi.org/10.1093/schizbullopen/sgac037

Hei, G., Smith, R. C., Li, R., Ou, J., Song, X., Zheng, Y., He, Y., Arriaza, J., Fahey, J. W., Cornblatt, B., Kang, D., Yang, Y., Huang, J., Wang, X., Cadenhead, K., Zhang, M., Davis, J. M., Zhao, J., Jin, H., & Wu, R. (2022). Sulforaphane Effects on Cognition and Symptoms in First and Early Episode Schizophrenia: A Randomized Double-Blind Trial. Schizophrenia Bulletin Open, 3(1). https://doi.org/10.1093/schizbullopen/sgac024

Thomas, M. D., Vittinghoff, E., Crystal, S., Walkup, J., Olfson, M., Khalili, M., Dahiya, P., Keenan, W., Cournos, F., & Mangurian, C. (2022). Hepatitis C Screening Among Medicaid Patients With Schizophrenia, 2002–2012. Schizophrenia Bulletin Open, 3(1). https://doi.org/10.1093/schizbullopen/sgab058